Quan Tran is a PhD student in the Department of Biological Sciences at the University of Notre Dame. In 2016, he received a medical degree from Pham Ngoc Thach University of Medicine in Vietnam. From 2016 to 2019, he worked as a research assistant in the Mathematical Modelling Unit at Oxford University Clinical Research Unit based in Vietnam, studying infectious diseases such as chikungunya and Japanese encephalitis. He started his PhD training at the University of Notre Dame in 2019 with a primary interest in arboviruses. His research interest involves combining quantitative methods and epidemiology with medical knowledge to tackle problems in emerging diseases.
He/him/his
United States
Gaythorpe KAM, Li X, Shankar M, Hartner AM, Gibney Z, Abbas K, Abeysuriya R, Alam C, Auzenbergs M, Azman AS, Barasa E, Costello A, Ferrari MJ, Fraser K, Fu H, Haile L, Kakaï RG, Karachaliou-Prasinou A, Lee EC, Katama EN, Kim JH, Jit M, Liu Y, Malinga J, Moore S, Nayagam S, Nedjati-Gilani G, Okell LC, Onifade AA, Papadopoulos T, Penny MA, Perkins TA, Pitzer VE, Portnoy A, Procter SR, Saraswati CM, Scott N, Seaman C, Shattock AJ, Sim SY, Tran Q, Vynnycky E, Winter AK, Hinsley W, Ferguson NM, Trotter CL. (2026). Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. Lancet, 407(10542)
Tran QM, Perkins TA. (2025). Misclassification of yellow fever vaccination status revealed through hierarchical Bayesian modeling. American journal of epidemiology
Brady OJ, Bastos LS, Caldwell JM, Cauchemez S, Clapham HE, Dorigatti I, Gaythorpe KAM, Hu W, Hussain-Alkhateeb L, Johansson MA, Lim A, Lopez VK, Maude RJ, Messina JP, Mordecai EA, Peterson AT, Rodriquez-Barraquer I, Rabe IB, Rojas DP, Ryan SJ, Salje H, Semenza JC, Tran QM. (2025). Why the growth of arboviral diseases necessitates a new generation of global risk maps and future projections. PLoS computational biology, 21(4)
Cavany S, Huber JH, Wieler A, Tran QM, Alkuzweny M, Elliott M, España G, Moore SM, Perkins TA. (2023). Does ignoring transmission dynamics lead to underestimation of the impact of interventions against mosquito-borne disease?. BMJ global health, 8(8)
Tran QM, Soda J, Siraj A, Moore S, Clapham H, Alex Perkins T. (2023). Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling. Vaccine, 41(1)
Huynh PK, Setty AR, Tran QM, Yadav OP, Yodo N, Le TQ. (2022). A domain-knowledge modeling of hospital-acquired infection risk in Healthcare personnel from retrospective observational data: A case study for COVID-19. PloS one, 17(11)
Lerch A, Ten Bosch QA, L'Azou Jackson M, Bettis AA, Bernuzzi M, Murphy GAV, Tran QM, Huber JH, Siraj AS, Bron GM, Elliott M, Hartlage CS, Koh S, Strimbu K, Walters M, Perkins TA, Moore SM. (2022). Projecting vaccine demand and impact for emerging zoonotic pathogens. BMC medicine, 20(1)
Li X, Mukandavire C, Cucunubá ZM, Echeverria Londono S, Abbas K, Clapham HE, Jit M, Johnson HL, Papadopoulos T, Vynnycky E, Brisson M, Carter ED, Clark A, de Villiers MJ, Eilertson K, Ferrari MJ, Gamkrelidze I, Gaythorpe KAM, Grassly NC, Hallett TB, Hinsley W, Jackson ML, Jean K, Karachaliou A, Klepac P, Lessler J, Li X, Moore SM, Nayagam S, Nguyen DM, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Sy S, Tam Y, Tanvir H, Tran QM, Trotter CL, Truelove S, van Zandvoort K, Verguet S, Walker N, Winter A, Woodruff K, Ferguson NM, Garske T, . (2021). Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet, 397(10272)
Perkins TA, Tran QM. (2021). Timing is everything when it comes to pertussis vaccination. The Lancet. Infectious diseases
España G, Cavany S, Oidtman R, Barbera C, Costello A, Lerch A, Poterek M, Tran Q, Wieler A, Moore S, Perkins TA. (2021). Impacts of K-12 school reopening on the COVID-19 epidemic in Indiana, USA. Epidemics, (37)
Perkins TA, Huber JH, Tran QM, Oidtman RJ, Walters MK, Siraj AS, Moore SM. (2021). Burden is in the eye of the beholder: Sensitivity of yellow fever disease burden estimates to modeling assumptions. Science advances, 7(42)
Brito AF, Machado LC, Oidtman RJ, Siconelli MJL, Tran QM, Fauver JR, Carvalho RDO, Dezordi FZ, Pereira MR, de Castro-Jorge LA, Minto ECM, Passos LMR, Kalinich CC, Petrone ME, Allen E, España GC, Huang AT, Cummings DAT, Baele G, Franca RFO, da Fonseca BAL, Perkins TA, Wallau GL, Grubaugh ND. (2021). Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil. Nature communications, 12(1)
Bron GM, Strimbu K, Cecilia H, Lerch A, Moore SM, Tran Q, Perkins TA, Ten Bosch QA. (2021). Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover. Pathogens (Basel, Switzerland), 10(6)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.